Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - CHANGE IN WORKING CAPITAL
Change in Working Capital ADAP - Adaptimmune Therapeutics plc
-25 M
LAST VALUE
-8.91%
2 YEAR CAGR
11.19%
5 YEAR CAGR
-39.89%
10 YEAR CAGR